Across the FDA-approved branded products (Wegovy, Ozempic, Saxenda, Rybelsus, Zepbound, Mounjaro, Trulicity, Victoza), the active ingredient and brand are the same molecule under a different label and indication
Adding amylin agonism to a dual or triple incretin agonist is mechanistically plausible, but the concern is stacked gastrointestinal burden: adding semaglutide alone pushed GI events from 54.0% to 79.6%, and discontinuations from 2.6% to 5.9%
10.1111/j.1528-1167.2005.00282.x 65
We will also consider any underlying health conditions, such as kidney or gastrointestinal issues, to ensure your safety
Each of these serious side effects requires prompt medical attention and should be discussed with a healthcare provider
In associazione con altri farmaci antidiabetici orali o insulina, quando questi non sono da soli in grado di garantire un controllo glicemico adeguato